Fmoc-4-Nitro-D-Phenylalanine

Fmoc-4-Nitro-D-Phenylalanine is a D-configured aromatic amino acid derivative bearing an Fmoc-protecting group on the amino functionality and a para-nitro substituent on the benzyl side chain. The chiral center at the alpha-carbon and the electron-withdrawing nitro group together create a well-defined stereochemical and reactivity profile that is compatible with protected amino acid handling and peptide coupling workflows. The Fmoc carbamate enables base-mediated removal under standard peptide synthesis conditions, while the nitro group can participate in selective redox transformations and downstream functionalization. Aromatic character and the nitro substituent support incorporation into peptide building blocks and synthetic intermediates used for structure-driven studies and functional molecule construction.

1. Peptide Synthesis

Fmoc-4-Nitro-D-Phenylalanine is applied in peptide synthesis as an Fmoc-protected D-amino acid building block for assembling stereochemically defined sequences. The Fmoc-protected amine supports routine peptide coupling chemistry, while the carboxylate functionality enables formation of amide bonds during solid-phase or solution-phase assembly. The D-configuration allows access to peptide analogs with altered backbone stereochemistry, and the para-nitro side chain provides a handle for post-coupling modification without disturbing the peptide linkage. Nitro-bearing aromatic residues can be retained for electronic or recognition effects in peptide scaffolds or converted into other functional groups after chain assembly. Downstream peptide analogs prepared from this chiral intermediate can be used to probe conformational behavior and side-chain-dependent molecular recognition.

2. Side-Chain Functionalization

Fmoc-4-Nitro-D-Phenylalanine supports side-chain functionalization strategies in synthetic organic chemistry and chemical biology workflows. The para-nitro group on the phenyl ring can undergo controlled redox and derivatization pathways to generate downstream aniline, hydroxylamine, or other transformed aromatic motifs while preserving the stereogenic alpha-carbon. The Fmoc-protected amine and protected acid functionality enable the compound to be carried through multi-step sequences as a stable chiral intermediate, then deprotected or coupled when needed. The resulting nitro-to-functional-group conversion can be used to tune polarity, hydrogen-bonding capacity, and aromatic electronics in peptidomimetics and labeled probes. This makes the compound a practical precursor for producing functionalized amino acid derivatives and peptide-compatible intermediates for further chemical diversification.

3. Peptidomimetics And SAR Studies

Fmoc-4-Nitro-D-Phenylalanine is suitable for peptidomimetic construction and structure-activity relationship studies where stereochemistry and side-chain electronics must be controlled. The D-amino acid backbone incorporation can modulate proteolytic stability and conformational preferences in peptide-like scaffolds, while the para-nitro substituent provides a defined electron-withdrawing aromatic group for SAR mapping. The Fmoc group allows stepwise incorporation into analog libraries, and the nitro side chain can be retained as a functional reporter or transformed to probe how electronic and hydrogen-bonding changes affect molecular recognition. The chiral, protected amino acid format supports parallel synthesis of analog series with consistent stereochemical identity across candidates. Downstream, the prepared peptidomimetics can serve as chemically defined tools for evaluating binding-site preferences and for guiding iterative scaffold refinement.

4. Chemical Biology Probes

Fmoc-4-Nitro-D-Phenylalanine can be employed in chemical biology research to generate peptide-based probes and taggable molecular constructs. The aromatic nitro functionality provides a chemically addressable moiety that can be used in probe design workflows, including conversion to alternative functional groups for conjugation or detection chemistry. The Fmoc-protected amine enables incorporation into short peptide sequences that act as binding motifs, while the D-configuration helps produce probes with altered stability profiles relative to L-analog peptides. The resulting probe scaffolds can be used for studying biomolecular interactions, mapping binding interfaces, or building modular recognition elements for downstream conjugation. This amino acid derivative thus functions as a stereochemically controlled intermediate for producing chemically defined biochemical research reagents.

5. Pharmaceutical Intermediate Preparation

Fmoc-4-Nitro-D-Phenylalanine is relevant to pharmaceutical intermediate preparation and fine chemical synthesis where protected chiral amino acid derivatives are required as manufacturing-grade building blocks. The Fmoc carbamate provides a robust protection strategy for the amino group during controlled synthetic sequences, and the carboxyl functionality supports conversion into activated derivatives for downstream coupling or derivatization steps. The para-nitro aromatic side chain can serve as a controlled intermediate for generating alternative aryl functionalities used in medicinal chemistry programs. The stereochemical integrity of the D-alpha-carbon supports the production of enantiomerically defined intermediates that can be carried into peptide-like or peptidomimetic chemotypes. This positions the compound as a chiral amino acid intermediate compatible with process chemistry routes that rely on protected amino acid handling and predictable functional group transformations.

1. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

2. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

3. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

5. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency